Salivary gland ultrasound is linked to the autoimmunity profile in patients with primary Sjögren's syndrome
- PMID: 29644928
- PMCID: PMC7113485
- DOI: 10.1177/0300060518767031
Salivary gland ultrasound is linked to the autoimmunity profile in patients with primary Sjögren's syndrome
Erratum in
-
Corrigendum: Salivary gland ultrasound is linked to the autoimmunity profile in patients with primary Sjögren's syndrome.J Int Med Res. 2018 Sep;46(9):3991. doi: 10.1177/0300060518797229. Epub 2018 Aug 21. J Int Med Res. 2018. PMID: 30130986 Free PMC article. No abstract available.
Abstract
Objective: Salivary gland ultrasound (SGU) is a reliable technique for assessing the salivary glands in patients with primary Sjögren’s syndrome (pSS). The aim of this study was to elucidate the relationship between SGU findings and autoimmunity in patients with pSS.
Methods: Patients with pSS underwent an SGU assessment. The patients were classified into three groups according to their autoimmunity profile: the complete positive group (positive rheumatoid factor, antinuclear antibodies, and anti-Ro/anti-La antibodies), the partial seropositive group (positivity of at least one autoantibody but not all), and the seronegative group.
Results: In total, 93 patients were evaluated. Eighty-six (92.5%) were female, and their median age was 49.5 years. The median disease duration was 12.3 years. Pathological SGU findings were present in 32 (34.4%) patients [25 of 36 (78.1%) in the complete positive group and 7 of 44 (21.9%) in the partial positive group]. Patients with pathological SGU findings had a shorter disease duration and slightly higher European League Against Rheumatism Sjögren’s syndrome disease activity index.
Conclusions: The autoimmunity profile and pathological SGU findings are strongly associated with each other in patients with pSS. However, the disease duration does not seem to be related to pathological SGU findings.
Keywords: Sjögren’s syndrome; autoantibodies; autoimmunity profile; disease activity index; disease duration; salivary gland ultrasound.
References
-
- Ramos-Casals M, Solans R, Rosas J, et al. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008; 87: 210–219. - PubMed
-
- Beckman KA, Luchs J, Milner MS, et al. The potential role for early biomarker testing as part of a modern, multidisciplinary approach to Sjögren’s syndrome diagnosis. Adv Ther 2017; 34: 799–812. - PubMed
-
- Seror R, Ravaud P, Mariette X, et al. EULAR Sjogren´s syndrome Patient Reported Indez (ESSPRI): development of a consensus patient index fro primary Sjogren´s syndrome. Ann Rheum Dis 2011; 70: 968–972. - PubMed
-
- Seror R, Theander E, Brun JG, et al. Validation of EULAR primary Sjögren´s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 2015; 74: 859–866. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
